Bavarian Nordic Logo

Bavarian Nordic

BAVA | CO

Overview

Corporate Details

ISIN(s):
DK0015998017 (+1 more)
LEI:
2138006JCDVYIN6INP51
Country:
Denmark
Address:
PHILIP HEYMANS ALLE 3, 2900 HELLERUP
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bavarian Nordic is a fully integrated biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The company specializes in preventing infectious diseases through innovative vaccine technologies. It serves as a leading global provider of travel vaccines and is a key partner for governments and international organizations in delivering public health solutions. Bavarian Nordic manages the entire product lifecycle, from initial research and development through to large-scale manufacturing and distribution.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Bavarian Nordic. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-22 07:38
Earnings Release
English 1.2 MB
2025-08-22 07:38
Earnings Release
English 14.1 KB
2025-08-22 07:38
Earnings Release
English 1.2 MB
2025-08-22 07:38
Earnings Release
Danish 14.2 KB
2025-07-31 16:32
Share Issue/Capital Change
English 7.2 KB
2025-07-31 16:32
Earnings Release
English 152.9 KB
2025-07-31 16:32
Business and Financial Review
Danish 125.2 KB
2025-07-31 16:32
Earnings Release
Danish 7.2 KB
2025-07-24 15:56
Regulatory News Service
English 116.2 KB
2025-07-24 15:56
M&A Activity
English 116.2 KB
2025-07-24 15:56
M&A Activity
English 4.4 KB
2025-07-24 15:56
M&A Activity
English 4.4 KB
2025-07-09 16:46
Regulatory News Service
Danish 161.4 KB
2025-07-09 16:46
Regulatory News Service
Danish 6.6 KB
2025-07-09 16:46
Regulatory News Service
English 161.6 KB

Automate Your Workflow. Get a real-time feed of all Bavarian Nordic filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Bavarian Nordic via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
H. Lundbeck A Logo
Global pharmaceutical company creating innovative treatments for brain diseases.
Denmark HLUN
Hong Kong N/A
Hyloris Pharmaceuticals SA Logo
A biopharma company optimizing existing drugs for unmet needs via abbreviated pathways.
Belgium HYL
Idorsia Ltd Logo
Develops novel medicines for CNS, cardiovascular, immunological, and orphan diseases.
Switzerland IDIA
Immuno-Biological Laboratories Co., Ltd. Logo Japan 4570
Indivior PLC Logo
A global pharmaceutical firm developing treatments for addiction and mental illness.
United Kingdom INDV
Infant Bacterial Therapeutics Logo
Developing microbiome therapies for premature infants to prevent life-threatening intestinal disease.
Sweden IBT
Intercure Ltd. Logo
Producer of pharma-grade, GMP-certified medical cannabis products for patients outside North America.
Israel INCR
Intervacc AB Logo
Develops recombinant protein vaccines for animal health, led by its vaccine for equine strangles.
Sweden IVACC
Ipsen Logo
Develops transformative medicines for Oncology, Rare Diseases, and Neuroscience.
France IPN